Posted On: 01/11/2015 9:53:29 AM
Post# of 30066
Critical Mass is defined as:
" the existence of sufficient momentum in a system such that the momentum becomes self-sustaining and creates further growth."
http://www.merriam-webster.com/dictionary/critical%20mass
Inflection Point is defined as:
"an event that results in a significant change in the progress of a company, industry, sector, economy or geopolitical situation."
http://www.investopedia.com/terms/i/inflectionpoint.asp
" the existence of sufficient momentum in a system such that the momentum becomes self-sustaining and creates further growth."
http://www.merriam-webster.com/dictionary/critical%20mass
Inflection Point is defined as:
"an event that results in a significant change in the progress of a company, industry, sector, economy or geopolitical situation."
http://www.investopedia.com/terms/i/inflectionpoint.asp
Quote:
"In addition, the company is continuing the development of its reimbursement strategy (ref: CPT Codes) to support commercial sales, in addition to putting in place its LymPro's General Marketing Strategy. We believe putting all of the pieces in place for a successful launch of LymPro is crucial to its initial launch and establishment as the market leading blood diagnostic for AD." October 27th, 2014
Quote:
"As a holding company, our strategy is to acquire undervalued assets, incubate them through critical de-risking milestones and thereafter seek to deliver value to our shareholders through strategic initiatives. We believe we are well positioned to deliver on that promise in the near-term with our diagnostic division, making for the first data point of success of the overall business model and positioning Amarantus to continue this model as we move forward." October 27th, 2014
Quote:
"We have completed the necessary APP protocols required to confidently and reproducibly offer LymPro to the pharmaceutical industry, and we will now be able to offer this test to the pharmaceutical industry for use in their clinical development programs." December 22nd, 2014
Quote:
"We expect to announce additional significant news in the coming weeks regarding LymPro, as well as pending additions to our diagnostics division to buttress this business unit for a potential spin-off into a standalone entity." December 22nd, 2014
Quote:
"We are eagerly looking forward to working with small and large pharmaceutical companies on innovative programs that have a meaningful opportunity to improve the standard of care for AZ patients and their families." December 22nd, 2014
(0)
(0)
